Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (GlaxoSmithKline)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameDiphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (GlaxoSmithKline)
Drug Alias Name白喉、破伤风类毒素和无细胞百日咳疫苗 - 葛兰素史克Infanrix
ClassificationVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Toxoid vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRotavirus InfectionsPoliomyelitisStreptococcal Infections +[7] 
Global Approved IndicationsTetanusDiphtheriaWhooping Cough
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/01/29
Country/TerritoryUnited StatesNigeriaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsTetanusDiphtheriaWhooping Cough
Inactive IndicationsRotavirus InfectionsPoliomyelitisStreptococcal Infections +[4] 

Other Information

ATC CodeJ07AJ52
Related LinksN/A